Skip to main content
WeLoveTrump.com may receive compensation from affiliate partners for some links on the site. Read our full Disclosure here.

Mass Distribution of Ivermectin Leads to Dramatic Decline in COVID-19 Cases in India & Mexico


7,003 views

When we look back in history, the books will say that the global rollout of experimental COVID-19 vaccines saved the world from the devastating pandemic.

But those books will perpetuate a lie because the mainstream press and medical overlords continue to lie directly to the face of the public.

We hear that vaccines, lockdowns, and masks pulled us through COVID-19.

But they ignore natural immunity, seasonality, and effective treatments.

Why?

Because that doesn’t fill the pockets of Big Pharma and gives the populace more freedom to make personal decisions about their health.

One of the biggest lies is about the drug Ivermectin.

In wealthier countries like the United States, it’s near impossible to find it being used to treat COVID-19.

But if we investigate other countries that have used Ivermectin, the results have been astounding.

Take India & Mexico for example:

This is not a coincidence that the large-scale usage of Ivermectin has led to vast improvements for India’s COVID-19 predicament.

As I reported months ago, India kept cases down throughout 2020 and early 2021 by using a cheap, effective COVID treatment kit that contained Ivermectin.

The kit was priced under $3 per person.

But then the vaccine rollout commenced, which was followed by an implosion of cases.

Now that Ivermectin is readily utilized again, we’re seeing cases sharply decline.

However, the wicked liars of the mainstream press want you to believe otherwise.

They will shill for Big Pharma and cheer for experimental vaccines and lockdowns being the proponent of the decline in cases:

American Thinker had the scoop about Delhi’s dramatic reduction in cases:

India has been suffering horrendously from COVID of late, and the complete death toll may never be known. But in the capital city of Delhi, mass distribution of ivermectin began and the results have been stunning.

Stephen McIntyre of Climate Audit posted a Twitter thread that includes this remarkable graph:

This result is consistent with the results of mass distribution of ivermectin in Mexico City, as reported by James V. DeLong on these pages on May 21, 2021:

Yet, most doctors in this country refuse to prescribe ivermectin, and most hospitals in this country refuse to administer it even to seriously ill COVID patients, citing the lack of double-blind studies – which are expensive and time consuming and which yield no big profits for anyone since ivermectin is a generic drug with no patent protection.

A Buffalo, NY woman had to sue in order to receive ivermectin therapy while hospitalized, forced to bear considerable legal fees. After a judge ordered that she receive it, she recovered and left the hospital.

In poorer countries, where vaccines are unavailable to too expensive for mass use, they have been forced to resort to ivermectin. This has had the effect of conducting a mass experiment (albeit not with the double-blind, randomized, controlled conditions that “gold standard” medical research requires. Maybe that will enable the ivermectin deniers to maintain their posture of self-righteousness.

Note that the emergency use authorization under which the experimental mRNA vaccines have been approved for mass use would not be given if there were an accepted effective alternative therapy. Billions of dollars flowing into the hands of vaccine makers would not have happened.

Closer to home, Mexico is another country where COVID-19 cases have dramatically declined in the past several months.

Although establishment-approved health bureaucrats won’t acknowledge it, but the usage of Ivermectin has played a significant role in the improvements in Mexico.

In particular, in the metropolis of Mexico City and its 22 million inhabitants.

TrialSite News shared this info from Mexico City:

The nation of Mexico generally, and more specifically Mexico City, one of the world’s most populated cities with 22 million people, experienced a greater spike in COVID-19 cases by December 2020. It was at the end of 2020 that the Mexico City Government, concerned about hospital capacity, implemented an expanded population-based health intervention to manage COVID-19. Based on the growing data available from ivermectin research, the government organized a prehospital home-care program combining early detection with antigen tests, a phone-based monitoring process for positive patients and the provisioning of a medical kit containing ivermectin. Testing, based on World Health Organization (WHO) recommendations, was extended into a massive testing program in 230 temporary mobile units or “kiosks.” Fundamental in the Mexican mission: lower access barriers to identifying COVID-19 at early stages, reduce opportunity for transmission via home isolation and care for patients early, right at onset, even if asymptomatic or mild symptoms. The overall study commenced July 8, 2020 with 3,000 tests administered daily and by the middle of November, the government expanded capacity to 24,000 daily tests. Again, public health workers followed up on those deemed positive via Locatel, (Mexico City Government call center) or WhatsApp text service. During that call, patients are informed if they are positive, asked if they can be in isolation, and the symptoms, if escalated, prompt a more intensive monitoring protocol (e.g. every couple days in more severe cases). Serious cases prompt 911 and hospitalization. Since December 28, the ivermectin-based medical kits were distributed to mild to moderate symptomatic patients. The Mexico City Government sought to measure the effectiveness of this population-wide intervention inclusive of the ivermectin-based medical kit in overall hospitalization during the pandemic. Using a quasi-experimental research design involving a Coarsened Exact Matching method leveraging hospital and phone call monitoring data, the study team estimated logistic-regression models with a range of observational data and found a significant reduction in hospitalizations among the cohort receiving ivermectin-based medical kit. In fact, the range of positive effect totaled 52% to 76% depending on model specification. The team concluded that ivermectin-based interventions in a well-designed population-level scheme mitigates the effects of the COVID-19 pandemic on the health system in the world’s fifth largest city. TrialSite includes diagrams of the impact these population-level schemes have had in the region. The results should trigger public health discussions in other large metropolitan areas. This study included over 200,000 people.

The Mexican City news was covered in various press and YouTube interviews but not widely translated in the rest of North America. Dr Vincent Mondragon explained how and when the Mexican IMSS started using ivermectin. Population health professional Juan Chamie reported to TrialSite that the IMSS was using ivermectin in the early stages of COVID. A government health plan, IMSS is used by about half of the Mexican population, and over 60 million people.

The suppression of Ivermectin usage across the globe and refusal by doctors to make it accessible to patients is one of the greatest crimes of COVID-19 hysteria.

The people complicit with the censorship of cheap, effective COVID-19 treatments in favor of experimental vaccines have blood on their hands.

And they should be charged with crimes against humanity.



 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

We Love Trump
Thanks for sharing!
Send this to a friend